ライフサイエンスコーパス: Bacteroides fragilis

1 n of dizinc metallo-beta-lactamase CcrA from Bacteroides fragilis.

2 ivated lamina propria lymphocytes (LPLs), or Bacteroides fragilis.

3 Sp1 and our previously determined PS A2 from Bacteroides fragilis.

4 pared cell extracts of the obligate anaerobe Bacteroides fragilis.

5 vestigate the within-microbiome evolution of Bacteroides fragilis.

6 semination of antibiotic resistance genes in Bacteroides fragilis.

7 ivity associated with the choA orthologue in Bacteroides fragilis.

8 alkyl hydroperoxide reductase (ahp) gene in Bacteroides fragilis.

9 ivalis but not that from Escherichia coli or Bacteroides fragilis.

10 identical residues) to the RecA protein from Bacteroides fragilis.

11 ulture of which grew E. coli, Prevotella and Bacteroides fragilis.

12 to carbapenems, is of increasing concern in Bacteroides fragilis.

13 gut microbiota, Escherichia coli Nissle and Bacteroides fragilis.

14 A from Thomasclavelia ramosa and BF3526 from Bacteroides fragilis.

15 system (T6SS) shuts down the native T6SS of Bacteroides fragilis.

16 ISPR-encoded NrN family phosphodiesterase in Bacteroides fragilis.

17 teus mirabilis, Lactobacillus johnsonii, and Bacteroides fragilis.

18 I from the anaerobic Gram-negative bacterium Bacteroides fragilis.

19 icobacter pylori, Clostridium difficile, and Bacteroides fragilis.

20 nsal bacteria including Escherichia coli and Bacteroides fragilis.

21 homologue of RprY, a response regulator from Bacteroides fragilis.

22 ts containing Escherichia coli (150 CFU) and Bacteroides fragilis (10(4) CFU) into the abdominal cavi

23 , the Streptococcus anginosus group (56.7%), Bacteroides fragilis (46.6%), and Pseudomonas aeruginosa

24 polysaccharide biosynthesis locus, PS B2, of Bacteroides fragilis 638R are described, and the sequenc

25 ysaccharide, PS A2, from the clinical strain Bacteroides fragilis 638R.

26 e (FKP), a bifunctional enzyme isolated from Bacteroides fragilis 9343, which converts l-fucose into

27 nimals with the ubiquitous gut microorganism Bacteroides fragilis, a bacterial polysaccharide (PSA) d

28 rized the soluble NFeoAB fusion protein from Bacteroides fragilis, a commensal organism implicated in

29 label various commensal anaerobes, including Bacteroides fragilis, a common and immunologically impor

30 Bacteroides fragilis, a component of the normal intestin

31 tic mechanism of metallo-beta-lactamase from Bacteroides fragilis, a dinuclear Zn(II)-containing enzy

32 Bacteroides fragilis, a Gram-negative colonic bacterium,

33 lates of several bacterial strains including Bacteroides fragilis, a pathogen commonly found in suppu

34 a different type of phase-variable system of Bacteroides fragilis, a Type I restriction modification

35 Although Bacteroides fragilis accounts for only 0.5% of the norma

36 demonstrate that the prominent gut commensal Bacteroides fragilis activates the TLR pathway to establ

37 hich is produced by the intestinal commensal Bacteroides fragilis, activates CD4+ T cells, resulting

38 efficient capsule biogenesis in E. coli and Bacteroides fragilis also depends on processive antiterm

39 tify complex functional interactions between Bacteroides fragilis, an invertible promoter, a capsular

40 The obligately anaerobic bacterium Bacteroides fragilis, an opportunistic pathogen and inha

41 plex between the metallo-beta-lactamase from Bacteroides fragilis and 4-morpholinoethanesulfonic acid

42 C57B/6 mice were untreated or treated with Bacteroides fragilis and antibiotic-mediated depletion o

43 : C57B/6 mice were untreated or treated with Bacteroides fragilis and antibiotic-mediated depletion o

44 The combination of Bacteroides fragilis and Bacillus subtilis consistently

45 NR fecal microbiomes were enriched for Bacteroides fragilis and Bacteroides salyersiae strains

46 We characterized HmuY homologs expressed by Bacteroides fragilis and compared their properties with

47 report a mechanism for HMO digestion by Bacteroides fragilis and demonstrate how the same pathwa

48 tative oriT region necessary for transfer in Bacteroides fragilis and Escherichia coli.

49 t dinuclear zinc metallo-beta-lactamase from Bacteroides fragilis and its complex with a biphenyl tet

50 Using Bacteroides fragilis and its OM-associated polysaccharid

51 cificity of the metallo-beta-lactamases from Bacteroides fragilis and other similar organisms is the

52 ave protein O-glycosylation systems, that of Bacteroides fragilis and related species is unique in th

53 g LPS structures of various bacteria such as Bacteroides fragilis and Salmonella abortus are observed

54 gainst abscesses induced by bacteria such as Bacteroides fragilis and Staphylococcus aureus.

55 vely, our findings support a causal role for Bacteroides fragilis and the PUFA metabolites in activat

56 Here we show that Bacteroides fragilis and their metabolites 12-hydroxy-he

57 olysaccharide C (PS C) biosynthesis locus of Bacteroides fragilis and to determine whether distinct l

58 n new work with and vaccine development with Bacteroides fragilis and Yersinia, Shigella, and Salmone

59 pathogens, including Staphylococcus aureus, Bacteroides fragilis, and a combination of Enterococcus

60 ntibiofilm effects on Staphylococcus aureus, Bacteroides fragilis, and Candida albicans are investiga

61 mixed cultures containing Escherichia coli, Bacteroides fragilis, and Clostridium perfringens.

62 ing Fusobacterium nucleatum, enterotoxigenic Bacteroides fragilis, and colibactin-producing Escherich

63 -producing Escherichia coli, enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum, for t

64 uding those found in Haemophilus influenzae, Bacteroides fragilis, and Proteus mirabilis.

65 ed to Stenotrophomonas maltophilia, to a few Bacteroides fragilis, and to rare pathogens.

66 hpCF, dps, and katB in the obligate anaerobe Bacteroides fragilis are controlled by the redox-sensiti

67 Strains of Bacteroides fragilis associated with diarrhea in childre

68 Strains of Bacteroides fragilis associated with diarrheal disease (

69 (Omp200, composed of Omp121 and Omp71) from Bacteroides fragilis ATCC 25285 was purified and tryptic

70 The proteinase was recovered from Bacteroides fragilis ATCC 25285(pFD340-prtP) cells by 3-

71 d to T-cell stimulating immunogen PS A1 from Bacteroides fragilis ATCC 25285/NCTC 9343 via a physiolo

72 Bacteroides fragilis (B. fragilis) has been identified a

73 f Fusobacterium nucleatum (F. nucleatum) and Bacteroides fragilis (B. fragilis) in the gut is associa

74 etobacter baumannii, Neisseria meningitidis, Bacteroides fragilis, Bacillus anthracis, Yersinia pesti

75 Bacteroides fragilis (BF) is an integral component of th

76 sed of Bacteroides thetaiotaomicron (Bt) and Bacteroides fragilis (Bf), two representative human comm

77 -galactosylceramides from the human symbiont Bacteroides fragilis (BfaGCs).

78 Despite the documented use of the FKP from Bacteroides fragilis (BfFKP), the evolutionary origins o

79 g glycoantigen (GlyAg) polysaccharide A from Bacteroides fragilis but not conventional peptides.

80 ored by colonization with a human commensal, Bacteroides fragilis, but not with a polysaccharide A (P

81 el is inconsistent with the observation that Bacteroides fragilis can colonize the colon in the absen

82 Gut symbiont Bacteroides fragilis can produce alpha-galactosylceramid

83 Bacteroides fragilis can replicate in atmospheres contai

84 rom the Gram-negative opportunistic pathogen Bacteroides fragilis, can rescue the ultraviolet sensiti

85 The Bacteroides fragilis capsular polysaccharide complex is

86 gulatory mechanism is similar to that of the Bacteroides fragilis capsular polysaccharides and establ

87 d a 1.94 angstrom X-ray crystal structure of Bacteroides fragilis CASDH by molecular replacement.

88 P-beta-l-fucose pyrophosphorylase (FKP) from Bacteroides fragilis catalyzes the conversion from l-fuc

89 s directed to a preferred target site in the Bacteroides fragilis chromosome by a transposon-encoded

90 7, a new 52-kb transfer factor isolated from Bacteroides fragilis clinical isolate LV23.

91 nd was isolated from an antibiotic resistant Bacteroides fragilis clinical isolate.

92 developed to detect the bft gene subtypes in Bacteroides fragilis clinical isolates.

93 lent bacterial gastrointestinal inhabitants: Bacteroides fragilis, Clostridium perfringens, Escherich

94 ulfate-induced) and chronic (enterotoxigenic Bacteroides fragilis) colitis, and systemic infection wi

95 performed using "Fusobacterium nucleatum", "Bacteroides fragilis", "Colorectal cancer" and all relev

96 The Bacteroides fragilis conjugal plasmid pBFTM10 contains t

97 The symbiont Bacteroides fragilis constitutes a relatively small prop

98 Bacteroides fragilis constitutes about 1% of the bacteri

99 nt of MIA offspring with the human commensal Bacteroides fragilis corrects gut permeability, alters m

100 The human commensal Bacteroides fragilis delivers immunomodulatory molecules

101 Bacteroides fragilis-derived LPS, however, can effective

102 s of two Uxs-type UDP-GlcA decarboxylases of Bacteroides fragilis, designated BfUxs1 and BfUxs2.

103 -resistant mice gavaged with murine-isolated Bacteroides fragilis develop P. yoelii hyperparasitemia.

104 de, PSA, produced by the commensal bacterium Bacteroides fragilis directs development of the immune s

105 ort herein that a prominent human commensal, Bacteroides fragilis, directs the development of Foxp3(+

106 aerobic commensal and opportunistic pathogen Bacteroides fragilis does not synthesize the tetrapyrrol

107 ingly, recolonization with live but not dead Bacteroides fragilis elicited AD pathologies in Thy1-C/E

108 on of CRC-associated species Enterotoxigenic Bacteroides fragilis, Enterococcus faecalis and Fusobact

109 enzyme from Bacillus cereus differs from the Bacteroides fragilis enzyme in sequence, zinc stoichiome

110 inally in two Bacteroides clinical isolates, Bacteroides fragilis ERL and B. thetaiotaomicron DOT.

111 taphylococci (CNS), Peptostreptococcus spp., Bacteroides fragilis, Escherichia coli, Enterococcus spp

112 pathogenic bacterial species enterotoxigenic Bacteroides fragilis (ETBF) and implanted particulate ma

113 Enterotoxigenic Bacteroides fragilis (ETBF) causes diarrhea and is impli

114 Enterotoxigenic Bacteroides fragilis (ETBF) cells produce a 20-kDa heat-

115 Enterotoxigenic Bacteroides fragilis (ETBF) expresses B. fragilis toxin

116 Enterotoxigenic Bacteroides fragilis (ETBF) has been implicated in infla

117 Enterotoxigenic Bacteroides fragilis (ETBF) is a commensal bacterium of

118 Enterotoxigenic Bacteroides fragilis (ETBF) is a Gram-negative, obligate

119 tinal disease, the bacterium enterotoxigenic Bacteroides fragilis (ETBF) is a significant source of c

120 The human commensal enterotoxigenic Bacteroides fragilis (ETBF) is linked to both inflammato

121 Enterotoxigenic Bacteroides fragilis (ETBF) produces the Bacteroides fra

122 Enterotoxigenic Bacteroides fragilis (ETBF) secretes a 20-kDa metallopro

123 Enterotoxigenic Bacteroides fragilis (ETBF) strains produce a 20-kDa zin

124 Enterotoxigenic Bacteroides fragilis (ETBF) strains, which produce a 20-

125 gens, Arcobacter species and enterotoxigenic Bacteroides fragilis (ETBF), in 201 U.S. and European tr

126 ith the human gut bacterium, enterotoxigenic Bacteroides fragilis (ETBF), to investigate the link bet

127 The burden of enterotoxigenic Bacteroides fragilis (ETBF)-related diarrhea was determi

128 y a human colonic bacterium, enterotoxigenic Bacteroides fragilis (ETBF).

129 nse than toxigenic bacteria (enterotoxigenic Bacteroides fragilis [ETBF]).

130 at may promote such competition, we screened Bacteroides fragilis for the production of antimicrobial

131 Bacteroides fragilis, for example, synthesizes eight cap

132 Bacteroides fragilis GA3 is known to mediate potent inte

133 A Bacteroides fragilis gene (argF'(bf)), the disruption of

134 eq, hsRNA-Seq increased reads mapping to the Bacteroides fragilis genome by 48- and 154-fold in mucus

135 .6%), Porphyromonas species (11.3%), and the Bacteroides fragilis group (10.2%).

136 The predominant anaerobes were as follows: Bacteroides fragilis group (85 isolates), Peptostreptoco

137 Members of the Bacteroides fragilis group (BFG) reside in the human gas

138 Bacteroides fragilis group (BFG) species are common memb

139 (n = 43), Sphingobacterium spp. (n = 3), and Bacteroides fragilis group (n = 15).

140 The predominant anaerobes were Bacteroides fragilis group (n = 9) and Peptostreptococcu

141 Members of the Bacteroides fragilis group are among the most common ana

142 More Bacteroides fragilis group bacteremias were detected onl

143 which phenotypically resemble members of the Bacteroides fragilis group but phylogenetically display

144 robial susceptibility data of species of the Bacteroides fragilis group for 1989-1990 and 1998-1999 s

145 s bile sensitive and quite distinct from the Bacteroides fragilis group of anaerobes.

146 ntly better for several genera including the Bacteroides fragilis group, Fusobacterium, Clostridium,

147 One member of this family from Bacteroides fragilis had exquisite substrate specificity

148 Here, we demonstrate that Bacteroides fragilis has a general O-glycosylation syste

149 The human gut symbiont Bacteroides fragilis has a general protein O-glycosylati

150 Enterotoxigenic Bacteroides fragilis has been associated with diarrheal

151 nine biosynthesis in the anaerobic bacterium Bacteroides fragilis has been purified and crystallized

152 The chromosome of Bacteroides fragilis has been shown to undergo 13 distin

153 ated with colorectal cancer: enterotoxigenic Bacteroides fragilis, Helicobacter hepaticus or colibact

154 onts, including Bacteroides spp. (especially Bacteroides fragilis), Holdemania spp., Lachnobacterium

155 a, Streptococcus salivarius and depletion of Bacteroides fragilis in a cohort of one-year-old childre

156 is shows higher abundance of proinflammatory Bacteroides fragilis in AD-FMT mice.

157 olymerization of polysaccharide A (PSA) from Bacteroides fragilis in the endosome depends on the APC'

158 epeatedly acquires inactivating mutations in Bacteroides fragilis in the human gut.

159 specificity metallo-beta-lactamase CcrA from Bacteroides fragilis in the presence and absence of a ti

160 Survival of Bacteroides fragilis in the presence of oxygen was depen

161 We report a case of metronidazole-resistant Bacteroides fragilis in the United States and demonstrat

162 ssion of CcrA, a metallo-beta-lactamase from Bacteroides fragilis, in Escherichia coli requires a mut

163 munomodulatory molecule of the gut commensal Bacteroides fragilis, induces regulatory T cells to secr

164 ate early-phase immunologic events following Bacteroides fragilis infection in the peritoneal cavity,

165 g bacteria such as Staphylococcus aureus and Bacteroides fragilis initiate this host response when tr

166 tin capsules containing Escherichia coli and Bacteroides fragilis into the abdomens of rats (n = 9).

167 The opportunistic pathogen Bacteroides fragilis is a commensal organism in the larg

168 Bacteroides fragilis is a constituent of the normal resi

169 The anaerobe Bacteroides fragilis is a gram-negative, opportunistic p

170 The anaerobe Bacteroides fragilis is a highly aerotolerant, opportuni

171 Bacteroides fragilis is a member of the normal colonic m

172 t polysaccharide A (PSA) from the capsule of Bacteroides fragilis is a potent activator of CD4(+) T c

173 Enterotoxigenic anaerobic Bacteroides fragilis is a significant source of inflamma

174 Bacteroides fragilis is a universal member of the domina

175 jor clinical manifestation of infection with Bacteroides fragilis is the formation of intra-abdominal

176 Bacteroides fragilis is the leading cause of anaerobic b

177 Polysaccharide A (PSA) of Bacteroides fragilis is the model symbiotic immunomodula

178 Bacteroides fragilis is the most common anaerobe isolate

179 The obligate anaerobe, Bacteroides fragilis, is a highly aerotolerant intestina

180 The human intestinal microorganism, Bacteroides fragilis, is able to extensively modulate it

181 strate that the human colonic microorganism, Bacteroides fragilis, is able to modulate its surface an

182 The intestinal anaerobic symbiont, Bacteroides fragilis, is highly aerotolerant and resista

183 d that the anaerobic, opportunistic pathogen Bacteroides fragilis lacks the glutathione/glutaredoxin

184 content (SCC) and the gut commensal bacteria Bacteroides fragilis leads to IL-1B-dependent peritoniti

185 of Tn5520, a new mobilizable transposon from Bacteroides fragilis LV23.

186 e, we show that a single sialidase, NanH, in Bacteroides fragilis mediates stable occupancy of the in

187 coli R1, Pseudomonas aeruginosa PAC608, and Bacteroides fragilis), mixed together to form a cocktail

188 Here, we report that the intestinal microbe Bacteroides fragilis modifies the homeostasis of host in

189 A Bacteroides fragilis mutant resistant to hydrogen peroxi

190 We previously showed that a Bacteroides fragilis mutant unable to synthesize 4 of th

191 onic capsular polysaccharide of the anaerobe Bacteroides fragilis NCTC 9343, designated polysaccharid

192 ry to identify the sphingolipids produced by Bacteroides fragilis NCTC 9343.

193 ements were found in the genome sequences of Bacteroides fragilis NCTC9343 and Bacteroides thetaiotao

194 The gut commensal Bacteroides fragilis or its capsular polysaccharide A (P

195 t of Akkermansia muciniphila and decrease of Bacteroides fragilis (p < 0.05) were observed after 3 da

196 The genetic element flanking the Bacteroides fragilis pathogenicity island (BfPAI) in ent

197 yl-(1-3)-beta-glucopyranose (PGG)-glucan and Bacteroides fragilis polysaccharide A (PS A), were evalu

198 icha coli, beta-hemolytic streptococcus, and Bacteroides fragilis predominating.

199 metabolites, but symptoms are relieved by a Bacteroides fragilis probiotic.

200 Enterotoxigenic strains of Bacteroides fragilis produce an extracellular metallopro

201 Bacteroides fragilis produces a capsular polysaccharide

202 Bacteroides fragilis produces a capsular polysaccharide

203 n CNS demyelination, and we demonstrate that Bacteroides fragilis producing a bacterial capsular poly

204 investigated the cellular mechanism by which Bacteroides fragilis promotes the development of intraab

205 In the gut, Bacteroides fragilis protects against colitis through in

206 eport here that the prominent human symbiont Bacteroides fragilis protects animals from experimental

207 is factor for the human intestinal commensal Bacteroides fragilis, protects against central nervous s

208 sociated type III-B (Cmr) CRISPR system from Bacteroides fragilis provides immunity against mobile ge

209 In Bacteroides fragilis, PS synthesis is regulated so that

210 unomodulatory effects of the archetypal ZPS, Bacteroides fragilis PSA.

211 ysaccharides in the important human symbiont Bacteroides fragilis raised the critical question of how

212 We found a correlation between Bacteroides fragilis recovered and the level of inflamma

213 We reveal that Bacteroides fragilis releases PSA in outer membrane vesi

214 ebsiella oxytoca, Staphylococcus aureus, and Bacteroides fragilis remains largely undefined and test

215 mmensal bacteria, Bifidobacterium longum and Bacteroides fragilis, representative members of the gut

216 ibitory sphingolipids from symbiotic microbe Bacteroides fragilis represses 5-HT release.

217 F1687 proteins from Bacteroides vulgatus and Bacteroides fragilis respectively are members of the Pfa

218 T2159-BT2156 in a non-metabolizing relative, Bacteroides fragilis, resulted in gain of glucosinolate

219 tion of the ccf genes in the model symbiont, Bacteroides fragilis, results in colonization defects in

220 rystal structures of putative orthologs from Bacteroides fragilis, revealed a two-domain structure in

221 -terminal sequence of sialidases produced by Bacteroides fragilis SBT3182, another commensal enteric

222 The human gut symbiont Bacteroides fragilis secretes a ubiquitin homologue (BfU

223 The gut symbiont Bacteroides fragilis secretes an antimicrobial ubiquitin

224 pellets inoculated with Escherichia coli and Bacteroides fragilis (sepsis).

225 r, we uncovered a previously uncharacterized Bacteroides fragilis serine protease 1 (Bfp1) and show t

226 nd commensals, including Vibrio cholerae and Bacteroides fragilis, sheds light on our understanding o

227 ng animals with polysaccharide A (PS A) from Bacteroides fragilis shortly before or after challenge p

228 /-7 motifs (TTTG/TANNTTTG) were identical to Bacteroides fragilis sigma(ABfr) consensus -33/-7 promot

229 atalysis of metallo-beta-lactamase CcrA from Bacteroides fragilis, site-directed mutants of CcrA were

230 function of the metallo-beta-lactamase from Bacteroides fragilis, spectroscopic and metal-binding st

231 capsular polysaccharides of many strains of Bacteroides fragilis, Staphylococcus aureus, and Strepto

232 YT135.2.8, a Tn4400' insertion mutant of Bacteroides fragilis strain TM4000, grows poorly when us

233 Enterotoxigenic Bacteroides fragilis strains associated with childhood d

234 Bacteroides fragilis, Streptococcus pneumoniae, Prevotel

235 cillospira, Rickenellaceae, Parabacteroides, Bacteroides fragilis, Sutterella, Lachnospiraceae, 4-met

236 switching roles between the two species (as Bacteroides fragilis switches roles between humans and m

237 A single strain of Bacteroides fragilis synthesizes eight distinct capsular

238 Bacteroides fragilis synthesizes eight distinct capsular

239 tly nonmotile (Bacteroides thetaiotaomicron, Bacteroides fragilis, Tannerella forsythensis, Porphyrom

240 Strains of Bacteroides fragilis that produce a ca. 20-kDa heat-labi

241 Enterotoxigenic Bacteroides fragilis that secrete a zinc-dependent metal

242 ion system processes in metabolically active Bacteroides fragilis The ability to visualize fluorescen

243 factor contributing to the pathogenicity of Bacteroides fragilis, the most common anaerobic species

244 Bacteroides fragilis, though only a minor component of t

245 We further show that administering Bacteroides fragilis to aged wild-type male and female m

246 Here we show that administering Bacteroides fragilis to APP/PS1-21 mice increases Abeta

247 coli and bsh knockout and complementation in Bacteroides fragilis to demonstrate that BSH generates B

248 Using a mouse model for Bacteroides fragilis to explore the role of fucosylation

249 late KLE1738, which required the presence of Bacteroides fragilis to grow.

250 valuate the role of the C-terminal region in Bacteroides fragilis toxin (BFT) activity, processing, a

251 Bacteroides fragilis toxin (BFT) is a protein secreted b

252 The Bacteroides fragilis toxin (BFT) is the only known virul

253 role of the zinc-binding metalloprotease in Bacteroides fragilis toxin (BFT) processing and activity

254 high-level expression of biologically active Bacteroides fragilis toxin (BFT), we studied the express

255 The only known ETBF virulence factor is the Bacteroides fragilis toxin (BFT), which induces E-cadher

256 umor formation is dependent on ETBF-secreted Bacteroides fragilis toxin (BFT).

257 nic Bacteroides fragilis (ETBF) produces the Bacteroides fragilis toxin, which has been associated wi

258 A modified version of the Bacteroides fragilis transposon Tn4400, designated Tn440

259 P. gingivalis with a modified version of the Bacteroides fragilis transposon Tn4400.

260 ty, with nontoxigenic bacteria (nontoxigenic Bacteroides fragilis) triggering a stronger response tha

261 Here, we identify five genes in Bacteroides fragilis (tssNQOPR) that are essential for T

262 ntained on conserved ICE and are confined to Bacteroides fragilis Unlike GA1 and GA2 T6SS loci, most

263 the reaction pathway for binuclear CcrA from Bacteroides fragilis using density functional theory bas

264 ere, we reveal that the commensal bacterium, Bacteroides fragilis, utilizes canonical antiviral pathw

265 tyrosine site-specific recombinase (Tsr) of Bacteroides fragilis was characterized.

266 Bacteroides fragilis was detected in 83%, 100%, and 100%

267 e biosynthesis were depleted and the species Bacteroides fragilis was enriched in BEP-supplemented mo

268 As is typical, Bacteroides fragilis was positively associated with vagi

269 atB catalase gene in the anaerobic bacterium Bacteroides fragilis was studied.

270 a sixth target, the zinc beta-lactamase from Bacteroides fragilis, was screened against the fragment-

271 lysaccharide biosynthesis locus promoters of Bacteroides fragilis were determined from bacteria grown

272 le interactions with a common gut bacterium, Bacteroides fragilis, were studied.

273 de the promoter of polysaccharide A (PSA) of Bacteroides fragilis, which induces regulatory T cells (

274 f the opportunistic human anaerobic pathogen Bacteroides fragilis, which is currently classified as a

275 ch alters microbiome composition in favor of Bacteroides fragilis, which positively regulates cancer

276 We characterized the nanLET operon in Bacteroides fragilis, whose products are required for th

277 h faecal microbiota of Fut2 knockout mice or Bacteroides fragilis with lower surface fucosylation are

278 of Escherichia coli, Neisseria meningitidis, Bacteroides fragilis, Yersinia pestis, Chlamydia trachom

279 MD) simulations of the dinuclear form of the Bacteroides fragilis zinc beta-lactamase.

280 s a total synthesis of the repeating unit of Bacteroides fragilis zwitterionic polysaccharide A1 (PS